SUNIL AGARWAL Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SUNIL AGARWAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SUNIL AGARWAL. SUNIL AGARWAL is Director in Calithera Biosciences, Inc. ($CALA) and Chief Medical Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in MyoKardia Inc ($MYOK) and President of R & D in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Sana Biotechnology, Inc. ($SANA).
SUNIL AGARWAL in Ultragenyx Pharmaceutical Inc.
Trading Symbol: RAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SUNIL AGARWAL: Chief Medical Officer
Holdings: 9,136 shares
Current Value: $666,106
Latest Transaction: Aug 23 2016
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SUNIL AGARWAL in Ultragenyx Pharmaceutical Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CALA, JUNO, MYOK, SANA, RARE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 66.00 | 392 | 25,872 | 9,136 | 9.5 K to 9.1 K (-4.11 %) |
Jul 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 52.68 | 649 | 34,189 | 9,528 | 10.2 K to 9.5 K (-6.38 %) |
Jul 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 50.55 | 392 | 19,816 | 10,177 | 10.6 K to 10.2 K (-3.71 %) |
Jun 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 54.16 | 650 | 35,204 | 10,569 | 11.2 K to 10.6 K (-5.79 %) |
Jun 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 54.99 | 392 | 21,556 | 11,219 | 11.6 K to 11.2 K (-3.38 %) |
Jun 03 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Option Exercise | A | 70.57 | 26,700 | 1,884,219 | 26,700 | |
Jun 03 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Grant | A | 0.00 | 4,500 | 0 | 11,611 | 7.1 K to 11.6 K (+63.28 %) |
May 26 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 66.00 | 650 | 42,900 | 7,111 | 7.8 K to 7.1 K (-8.38 %) |
May 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 64.01 | 414 | 26,500 | 7,761 | 8.2 K to 7.8 K (-5.06 %) |
May 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 61.46 | 392 | 24,092 | 8,175 | 8.6 K to 8.2 K (-4.58 %) |
Mar 24 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 61.45 | 650 | 39,943 | 9,608 | 10.3 K to 9.6 K (-6.34 %) |
Mar 22 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 56.32 | 392 | 22,077 | 10,258 | 10.7 K to 10.3 K (-3.68 %) |
Feb 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 63.48 | 658 | 41,770 | 10,650 | 11.3 K to 10.7 K (-5.82 %) |
Feb 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 63.27 | 384 | 24,296 | 11,308 | 11.7 K to 11.3 K (-3.28 %) |
Apr 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 70.53 | 649 | 45,774 | 8,567 | 9.2 K to 8.6 K (-7.04 %) |
Apr 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 69.86 | 392 | 27,385 | 9,216 | 9.6 K to 9.2 K (-4.08 %) |
Jan 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 72.83 | 585 | 42,606 | 12,190 | 12.8 K to 12.2 K (-4.58 %) |
Jan 21 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 71.52 | 456 | 32,613 | 12,775 | 13.2 K to 12.8 K (-3.45 %) |
Dec 24 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 114.81 | 498 | 57,175 | 13,231 | 13.7 K to 13.2 K (-3.63 %) |
Dec 22 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 109.87 | 544 | 59,769 | 13,729 | 14.3 K to 13.7 K (-3.81 %) |
Nov 24 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 95.88 | 498 | 47,748 | 13,775 | 14.3 K to 13.8 K (-3.49 %) |
Nov 23 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 97.71 | 544 | 53,154 | 14,273 | 14.8 K to 14.3 K (-3.67 %) |
Oct 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 85.51 | 649 | 55,496 | 14,817 | 15.5 K to 14.8 K (-4.20 %) |
Oct 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 88.94 | 392 | 34,864 | 15,466 | 15.9 K to 15.5 K (-2.47 %) |
Sep 24 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 109.51 | 498 | 54,536 | 15,858 | 16.4 K to 15.9 K (-3.04 %) |
Sep 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 129.91 | 544 | 70,671 | 16,356 | 16.9 K to 16.4 K (-3.22 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Option Exercise | M | 55.88 | 10,000 | 558,800 | 140,000 | |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 111.90 | 930 | 104,070 | 16,900 | 17.8 K to 16.9 K (-5.22 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 111.21 | 2,000 | 222,428 | 17,830 | 19.8 K to 17.8 K (-10.09 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 110.40 | 4,875 | 538,181 | 19,830 | 24.7 K to 19.8 K (-19.73 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 108.98 | 1,471 | 160,310 | 24,705 | 26.2 K to 24.7 K (-5.62 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 107.30 | 724 | 77,687 | 26,176 | 26.9 K to 26.2 K (-2.69 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Buy | M | 55.88 | 10,000 | 558,800 | 26,900 | 16.9 K to 26.9 K (+59.17 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 112.73 | 3,650 | 411,459 | 16,900 | 20.6 K to 16.9 K (-17.76 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 112.19 | 3,370 | 378,078 | 20,550 | 23.9 K to 20.6 K (-14.09 %) |
Aug 21 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 116.99 | 5,480 | 641,105 | 23,920 | 29.4 K to 23.9 K (-18.64 %) |
May 27 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Option Exercise | A | 84.89 | 26,300 | 2,232,607 | 26,300 | |
May 27 2015 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Grant | A | 0.00 | 4,400 | 0 | 29,400 | 25 K to 29.4 K (+17.60 %) |
Aug 21 2014 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Option Exercise | A | 55.88 | 150,000 | 8,382,000 | 150,000 | |
Aug 21 2014 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Page: 1